Smart Textile Technology for Scoliosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02080611|
Recruitment Status : Withdrawn (Funding was not available from company)
First Posted : March 6, 2014
Last Update Posted : November 30, 2017
The investigators hypothesize that a garment-integrated sensing system will be able to detect with clinical accuracy the position of the spine. The investigator will evaluate this using healthy adult volunteers, who will don sensing garments and assume a series of spinal postures. Concurrent with garment sensing, the participant's spine position will be measured using a motion-capture system that uses reflective markers to detect positions of markers in 3D space.
The motion-capture system provides a gold-standard reference measure to which the sensing garments will be compared. Because the investigators are evaluating the accuracy of the sensing garment, it is only necessary that the investigator test the garments on participants with subtly different body shapes. Healthy adult volunteers provide an adequate input to the sensing signal.
|Condition or disease|
|Spinal Deformities Scoliosis Kyphosis|
|Study Type :||Observational|
|Actual Enrollment :||0 participants|
|Official Title:||Smart Textile Technology for Scoliosis: Aim 1|
|Study Start Date :||January 2016|
|Actual Primary Completion Date :||July 2016|
|Actual Study Completion Date :||July 2016|
- Body movement [ Time Frame: Participants will be assessed during a 1-2 hour visit. Visits will be scheduled over a period of approximately one year. ]The movement and position of participants' spine will be recorded using a motion capture device and using a prototype sensing garment during the 1-2 hour lab test. (This is the only point at which investigators will interact with participants)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02080611
|United States, Minnesota|
|University of Minnesota|
|Minneapolis, Minnesota, United States, 55455|
|Principal Investigator:||Lynne Dunn, PhD||University of Minnesota - Clinical and Translational Science Institute|